Assessing real-world treatment with SDZ ETN (an etanercept biosimilar) in people with rheumatic diseases included in the COMPACT study: a plain language summary
Bibliographic record
Abstract
Plain Language SummaryWhat is this summary about?This summary explains the findings of a clinical study called COMPACT, which included people treated with a medicine called SDZ ETN. In the COMPACT study, 1466 people from Europe and Canada were treated with an etanercept biosimilar medicine called Sandoz-etanercept (called SDZ ETN in this summary and sold under the brand name ErelziTM). The COMPACT study included people with three different rheumatic diseases that commonly affect the joints or the spine, but can also impact various organs, such as the skin and heart. These were rheumatoid arthritis, axial spondylarthritis, and psoriatic arthritis.What are the key takeaways?People experienced consistent treatment benefits, defined as improvements in the signs and symptoms of their disease when treated with SDZ ETN over 12 months. There were no new side effects with SDZ ETN in this study.What were the main conclusions reported by the researchers?The results of the real-world COMPACT study support the safe and effective use of SDZ ETN in people with rheumatoid arthritis, axial spondylarthritis, and psoriatic arthritis in everyday settings.This is an abstract of the Plain Language Summary of Publication article.View the full Plain Language Summary PDF of this article to read the full-text
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame distilled prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.
Codex and Gemma teacher scores by category
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.001 | 0.000 |
| Meta-epidemiology (narrow) | 0.000 | 0.000 |
| Meta-epidemiology (broad) | 0.001 | 0.000 |
| Bibliometrics | 0.000 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.000 | 0.000 |
| Open science | 0.000 | 0.000 |
| Research integrity | 0.000 | 0.000 |
| Insufficient payload (model declined to judge) | 0.000 | 0.000 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one teacher head, not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".